Haisco Pharmaceutical Group Co., Ltd. (002653)

Overview

Haisco Pharmaceutical Group Co., Ltd. is a leading pharmaceutical company based in Shannan, China, specializing in the research, development, manufacturing, and sales of pharmaceutical products within the Chinese market. The company was initially established in 2005 under the name Xizang Haisco Pharmaceutical Group Co., Ltd. before undergoing a rebranding to its current name in March 2016. Haisco Pharmaceutical Group has carved a niche for itself by offering an extensive range of pharmaceutical products across various therapeutic fields such as anesthesia, parenteral nutrition, tumor antiemetic, liver, gallbladder digestion, antibiotics, cardiovascular, and cerebrovascular diseases.

Products and Services

Haisco Pharmaceutical Group Co., Ltd. offers a diverse portfolio of pharmaceutical products, catering to a wide range of therapeutic needs. Here’s a closer look at some of their key products:

• Cycloporol - A product mainly used in the medical field for its specific health benefits.
• Dolasetron Mesylate - This product is utilized for its antiemetic properties, helping to prevent nausea and vomiting caused by surgery or cancer chemotherapy.
• Polyene Phosphatidylcholine - Used primarily to treat liver diseases, this compound supports the restoration and protection of liver cell membranes.
• Compound Amino Acid - This is designed for parenteral nutrition; it helps provide essential amino acids to patients who cannot eat or absorb them from food.
• Methylprednisolone Sodium Injections - Used in the treatment of various conditions, including allergies, asthma, arthritis, and immune system disorders. These injections work by mimicking the effects of steroids produced by the body.
• Flupenthixol Melitracen Tablets - A combination medication used for the treatment of mood disorders, providing relief from depression and anxiety.